Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre, Randomized, Controlled, Double-blind, Parallel Design Clinical Study to Evaluate the Efficacy, Safety and Tolerability of Vizol S DIGI EYE in the Adult Patient Population With Moderate to Severe Dry Eye Disease for up to 28 Days

NCT07050446 is registered in ClinicalTrials.gov with Jadran Galenski laboratorij d.d. as lead sponsor.

NCT NCT07050446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07050446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre, Randomized, Controlled, Double-blind, Parallel Design Clinical Study to Evaluate the Efficacy, Safety and Tolerability of Vizol S DIGI EYE in the Adult Patient Population With Moderate to Severe Dry Eye Disease for up to 28 Days
Lead sponsor
Jadran Galenski laboratorij d.d.
Phase
Phase 3
Overall status
Completed
Start date
March 20, 2024
Completion date
November 2, 2024
Enrollment
86 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease (ded)